news

« BACK

Health



Results 1 - 20 of 90.
1 2 3 4 5 Next »


Pharmacology - Health - 22.06.2022
Mugwort allergy: MedUni Vienna study creates basis for vaccine
A research team at MedUni Vienna has discovered key mechanisms of allergy to pollen from the common weed mugwort, thereby also laying the foundation for the development of the world's first vaccine. Mugwort (Artemisia vulgaris) poses a serious problem for allergic individuals in our latitudes from July through to September.

Health - Pharmacology - 21.06.2022
New blood biomarker identified for status of fatty liver disease
New blood biomarker identified for status of fatty liver disease
A MedUni Vienna study team has identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic fatty liver disease. As part of the immune system, these cells have a protective function against fibrosis and liver cirrhosis. At the same time, they are useful as biomarkers of liver disease progression as they can be measured by a blood test.

Health - Pharmacology - 15.06.2022
Covid-19: chronic liver disease patients at high risk of liver failure and bile duct damage
Patients with chronic liver disease may suffer hepatic complications as a result of severe Covid-19. A study conducted by a research team led by Lukas Hartl, Thomas Reiberger and Michael Trauner from the Division of Gastroenterology and Hepatology of MedUni Vienna and University Hospital Vienna found that a rise in cholestasis parameters and subsequent damage to the bile ducts, so-called secondary sclerosing cholangitis (SSC), develops with striking frequency in patients with pre-existing liver disease.

Health - 07.06.2022
Targeted micronutrition ameliorates allergy symptoms
Targeted micronutrition ameliorates allergy symptoms
Micronutrient deficiencies can promote inflammation and render the immune system particularly sensitive to allergenic substances. In particular, iron deficiency signals danger to immune cells and leads to a more pronounced, exaggerated immune response. For the first time, scientists at the Messerli Research Institute of MedUni Vienna, Vetmeduni Vienna and the University of Vienna conducted a placebo-controlled trial and showed that targeted dietary measures can reduce the symptom burden in allergic reactions.

Health - Pharmacology - 03.06.2022
Consistently high willingness to receive an annual COVID-19 booster vaccination
Consistently high willingness to receive an annual COVID-19 booster vaccination
In view of the constant emergence of new viral variants and the limited duration of immune protection through recovery or vaccination, it is becoming increasingly likely that an annual COVID-19 booster vaccination might be needed. Working with colleagues from the Transatlantic Research Lab on Complex Societal Challenges, Jakob Weitzer and Eva Schernhammer from the Department of Epidemiology at the Medical University of Vienna and Gerald Steiner from the University of Continuing Education Krems investigated the willingness of the population to be vaccinated annually against COVID-19.

Health - 02.06.2022
Decline in births among disadvantaged areas during the COVID-19 pandemic
Decline in births among disadvantaged areas during the COVID-19 pandemic
In the wake of the pandemic, there have been fewer births in poorer, more disadvantaged areas, while there has hardly been any change in births in affluent and more advantaged areas.

Health - 31.05.2022
Too much self-confidence can endanger health
Too much self-confidence can endanger health
Especially older people often overestimate their health Older people who overestimate their health go to the doctor less often. This can have serious consequences for their health, for example, when illnesses are detected too late. By contrast, people who think they are sicker than they actually are visit the doctor more often.

Health - Pharmacology - 19.05.2022
New non-invasive method of risk assessment in liver disease
In a recent study, an interdisciplinary research team from MedUni Vienna showed that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method for predicting complications in chronic liver disease. The scientists combined a simple risk stratification system developed at MedUni Vienna - the functional liver imaging score (FLIS) - with splenic diameter.

Health - Life Sciences - 18.05.2022
Viral infections during pregnancy affect maternal care behaviour
Viral infections during pregnancy affect the mother's brain and her postpartum care behaviour. These are the findings of a research study in a mouse model conducted at MedUni Vienna. The results were published in the leading journal "Molecular Psychiatry". There is ample data from studies in mouse models demonstrating that viral infections during pregnancy can affect the developing brain of the young in utero (in the womb) with lifelong consequences for brain function and behaviour.

Health - Life Sciences - 17.05.2022
Different subtypes defined in small cell lung cancer
Small cell lung cancer (SCLC) is a malignant disease associated with a particularly high mortality rate. According to a new multicenter study led by MedUni Vienna and conducted in collaboration with researchers from the Czech Republic, Hungary, Slovenia, Sweden and the United States, SCLC can be divided into several subgroups in terms of clinical behaviour.

Health - Pharmacology - 19.04.2022
New therapeutic option for head and neck carcinomas
The various manifestations of head and neck carcinomas rank sixth in frequency worldwide and are fatal for about half a million people every year. In a quarter of cases, head and neck squamous cell carcinoma (HNSCC) is caused by human papillomavirus (HPV) and, currently, is not always treatable. A research team led by Lorenz Kadletz-Wanke from MedUni Vienna's Department of Otorhinolaryngology and Head and Neck Surgery has now discovered a new therapeutic option in the context of a study.

Health - Pharmacology - 14.04.2022
Blood group as a marker for thrombosis risk in cancer patients
Blood group as a marker for thrombosis risk in cancer patients
A MedUni Vienna study found evidence that people with cancer and non-O blood group such as A, B or AB are at increased risk of developing venous thromboembolism (VTE), blood clots in the veins. The study was recently published in the journal "Blood Advances". VTE includes deep vein thrombosis (DVT), a blood clot that typically forms in the deep veins of the leg, and pulmonary embolism (PE), a life-threatening condition that occurs when a blood clot breaks free and lodges in the pulmonary arteries of the lungs.

Life Sciences - Health - 12.04.2022
Largest study of its kind links specific genes to schizophrenia
In the largest study so far conducted into schizophrenia, which included more than 320,000 participants, scientists from the Psychiatric Genomics Consortium (PGC), a group of several hundred researchers from 45 countries, identified a large number of genes that may play a significant role in the disorder.

Health - Pharmacology - 12.04.2022
Omicron: Number of vaccine breakthroughs in cancer patients on the rise
For cancer patients, Covid-19 poses a particular risk due to their often compromised immune systems, weakened by therapy or disease, which is why vaccination is very important for their protection. Now, a recent study led by MedUni Vienna shows that, due to Omicron, there is an increasing number of breakthrough infections in people with cancer, especially while they are undergoing cancer therapy.

Health - Life Sciences - 11.04.2022
Relieving symptoms in paraplegia
Up to 80% of people with a spinal cord injury suffer from spasticity. Until now, they had to choose between drugs with severe side effects or risky surgery. Mathematician and neuroscientist Ursula Hofstötter from the Medical University of Vienna developed a procedure that alleviates spasticity and also improves mobility - without any drugs or surgery.

Health - Life Sciences - 07.04.2022
Nerve Stimulation with the Help of Implantable Mini Solar Cells
Nerve Stimulation with the Help of Implantable Mini Solar Cells
An international research team has successfully developed and tested a concept in which nerves are stimulated with light pulses. The method provides considerable advantages for medicine and opens up a wide range of possible applications. Further images for download available at the end of the text The technology enables completely new types of implants that can be used to stimulate nerve cells and was developed in a joint effort by researchers from Graz University of Technology (TU Graz), the Medical University of Graz (Med Uni Graz), the University of Zagreb and the Czech CEITEC.

Health - Pharmacology - 05.04.2022
Newly developed COVID vaccine from Austria could protect against omicron and other variants
The preclinical data for a vaccine developed at MedUni Vienna to protect against SARS-CoV-2 indicates that it is effective against all SARS-CoV-2 variants known to date, including omicron - even in those who have not yet built up any immunity as a result of vaccination (non-responders). The data from the study were recently published in the leading journal "Allergy".

Life Sciences - Health - 17.02.2022
Investigating the waste in our cells: So that we can soon forget about Alzheimer's
Investigating the waste in our cells: So that we can soon forget about Alzheimer’s
Autophagy: What to do with the waste in our cells? A 'waste collection' tidies up our cells. If something does not go according to plan, serious diseases such as Alzheimer's or Parkinson's may develop. Molecular biologist Sascha Martens from the University of Vienna together with international partners - researchers of the University of Pennsylvania, Monash University, the Max Planck Institute of Biophysics in Frankfurt and the UC Berkeley - investigate the associated process: autophagy.

Health - Pedagogy - 27.01.2022
Schools and the pandemic: Simulation model allows for safe operation
Schools and the pandemic: Simulation model allows for safe operation
Developed during the ongoing pandemic, but expandable to different needs: Austrian scientists develop simulation model for keeping schools open safely during a pandemic. A year ago, the whole world was engaged in discussing the issue of opening schools during a pandemic: is it irresponsible to send children to school, or can schools be reopened safely if enough prevention measures are in place? A research team at the Complexity Science Hub Vienna (CSH) wanted to add some evidence to the discussion.

Health - Pharmacology - 22.12.2021
Covid-19 Infections in Nursing Homes: Simulation model for optimal prevention and vaccination strategies
Covid-19 Infections in Nursing Homes: Simulation model for optimal prevention and vaccination strategies
Researchers from TU Graz and Complexity Science Hub (CSH) Vienna have developed a detailed epidemiological model for the spread of the coronavirus in nursing homes. This enables optimal prevention strategies to be identified, as practical experience in Caritas nursing homes has shown. Since the beginning of the coronavirus pandemic, residents of nursing homes have been particularly at risk.
1 2 3 4 5 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |